The Shanghai Aging Study
The objective of this study is to establish a prospective cohort to enumerate the prevalence, and the incidence of dementia and mild cognitive impairment (MCI), and to investigate the risk and protective factors for these outcomes among residents aged 60 and over in an urban community of Shanghai, China.
Overview
- Acronym
- SAS
- Investigators
-
- Contacts
-
General Design
- Study design
- Cohort
- Start - End Year
- 2010 -
- General Information on Follow Up (profile, frequency)
-
Participants were assessed from January 2010 through September 2011 and were followed up in March 2014 to September 2015.
- Recruitment Target
-
- Individuals
- Number of Participants
- 3,141
- Number of Participants with Biological Samples
- 2,860
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
|
Marker Paper
Ding D.et al. The Shanghai Aging Study: Study Design, Baseline Characteristics, and Prevalence of Dementia. Neuroepidemiology. 2014;43:114-122.
PUBMED 25376362Timeline
Population
SAS - Population
The population is composed of men and women aged 60 and over that are part of the registered residents of the Jingansi community in downtown Shanghai, PR China.
Selection Criteria
- Minimum age
-
60
- Countries
-
- China
- Territory
- Shanghai
- Health Status
-
- Exclusion criteria: suffering from schizophrenia or mental retardation based on their medical records
- Other Criteria
- Exclusion criteria: not being able to communicate and accept physical and cognitive examinations
Sources of Recruitment
- Specific Population
-
- Other specific population : Registered residents in the Jingansi community
- Supplementary Information
-
Potential subjects were identified using a government maintained ‘residents list'. Before the study, coordinators went to each home in the community to introduce the study at the door. Individuals who were eligible and willing to participate were consecutively enrolled. A clinical interview (either at Huashan Hospital or at the subjects' homes) appointment was made. A reminder telephone call was also made to the subjects one day before the interview.
Sample Size
- Number of Participants
- 3,141
- Number of Participants with Biological Samples
- 2,860
Data Collection Events
| # | Name | Data sources | Data sources - Biosamples | Start | End |
|---|---|---|---|---|---|
| 0 | SAS - Baseline |
|
|
2010 (January) | 2011 (September) |
| 1 | SAS - Follow-up |
|
2014 (March) | 2016 (December) |
Participating Studies
| Acronym | Name | Study design | Countries |
|---|
Harmonization Initiatives Included
| Acronym | Name |
|---|
Datasets
| Name | Data Collection Events | Variables |
|---|
Areas of Information Collected
- Socio-demographic and economic characteristics
- Death
- Lifestyle and behaviours
- Physical measures and assessments
- Birth, pregnancy and reproductive health history
- Laboratory measures
- Perception of health, quality of life, development and functional limitations
- Cognition, personality and psychological measures and assessments
- Diseases
- Life events, life plans, beliefs and values
- Symptoms and signs
- Preschool, school and work life
- Medication and supplements
- Social environment and relationships
- Non-pharmacological interventions
- Physical environment
- Health and community care services utilization
- Administrative information
Variables Content Summary
Areas of Information Collected
No Areas of Information Collected
No Scales Collected
Areas of Information Collected per per Population and Data Collection Event
No Areas of Information Collected
No Scales Collected
Networks
| Acronym | Name | Harmonization Initiatives | Individual Studies |
|---|
Last Update: 2023-08-10T18:18:36.040